Form 4: Semler Scientific CFO Exercises Stock Options and Transfers Shares to Family Trust

Semler Scientific's Chief Financial Officer, Renae Cormier, exercised stock options for 3,746 shares and subsequently transferred them to a family revocable trust, maintaining beneficial ownership.

Summary

• Renae Cormier, Chief Financial Officer of Semler Scientific, Inc. (SMLR), exercised stock options to acquire 3,746 shares of common stock on June 11, 2025.
• The exercise price for these shares was $30.48 per share.
• Immediately following the exercise, Ms. Cormier transferred the 3,746 shares to the Cormier Family Revocable Trust for no consideration.
• Ms. Cormier is the trustee of the trust, and she and her immediate family are the sole beneficiaries, meaning she retains beneficial ownership of the transferred shares.
• After these transactions, Ms. Cormier directly holds 1,254 unexercised stock options.
• The original stock option grant, from which these shares were exercised, had a vesting schedule where 1/4th vested on May 17, 2023, and 1/48th vests monthly thereafter, with full vesting by May 17, 2026.

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction (option exercise and trust transfer) which is generally neutral but can be seen as slightly positive as the CFO is exercising options, indicating some level of confidence. There are no negative implications for the company or its stock price from this specific filing.

Positives

• The exercise of stock options by a key executive like the CFO can signal confidence in the company's future prospects.
• The transfer to a family trust for estate planning purposes is a common practice and does not indicate a sale into the open market, thus avoiding immediate downward pressure on the stock price.

Negatives

• No direct negatives are apparent from this Form 4 filing, as it primarily reports an option exercise and an internal transfer of beneficial ownership.

Risks

• No specific risks are mentioned or implied in this Form 4 filing, which is a routine insider transaction report.

Future Outlook

The vesting schedule indicates that the remaining 1,254 stock options held by Ms. Cormier will continue to vest monthly, with full vesting expected by May 17, 2026. This suggests potential future exercises or holdings by the CFO.

Industry Context

This Form 4 filing reports a routine insider transaction, specifically an option exercise and subsequent transfer to a trust, which is a common event for executives across all industries. It reflects ongoing executive compensation activities within Semler Scientific, which operates in the healthcare technology sector, but does not provide insights into broader industry trends.

Stakeholder Impact

• Shareholders: The exercise of options by a CFO can be viewed as a positive signal of management's belief in the company's value, though the subsequent transfer to a trust means no immediate market sale pressure.
• Employees: No direct impact on employees is indicated by this transaction.
• Customers: No direct impact on customers is indicated by this transaction.
• Suppliers: No direct impact on suppliers is indicated by this transaction.
• Creditors: No direct impact on creditors is indicated by this transaction.

Next Steps

• Continued monthly vesting of the remaining 1,254 stock options held by Renae Cormier until full vesting on May 17, 2026.

Key Dates

Recommendation

Keywords

Semler Scientific, SMLR, Form 4, Stock Option Exercise, Insider Transaction, Renae Cormier, CFO, Beneficial Ownership, Trust Transfer, Executive Compensation